Mkt Cap $1.6B
52-Week Range
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
Revenue is primarily driven by Product (29.1%) and Connected Devices Software Licenses And Other (25.1%).
Most recently: of this Current Report on Form 8-K and Exhibit 99.1 attached hereto are being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securi (2026-02-05).
$1.6B
Market Cap
$1.2B
Revenue
$2M
Net Income
Revenue by Segment
Revenue by Geography